AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
GILD   74.71 (-1.19%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
NFLX   507.76 (+0.99%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
GILD   74.71 (-1.19%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
NFLX   507.76 (+0.99%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
GILD   74.71 (-1.19%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
NFLX   507.76 (+0.99%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
GILD   74.71 (-1.19%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
NFLX   507.76 (+0.99%)
BA   173.28 (-3.78%)
Log in

NASDAQ:AZRXAzurRx BioPharma SEC Filings & 10K Form

$0.83
0.00 (-0.06 %)
(As of 07/9/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.82
Now: $0.83▼
$0.90
50-Day Range
$0.80
MA: $0.90▼
$1.02
52-Week Range
$0.37
Now: $0.83▼
$1.94
Volume82,504 shs
Average Volume377,021 shs
Market Capitalization$23.54 million
P/E RatioN/A
Dividend YieldN/A
Beta2.03

SEC Filings

AzurRx BioPharma (NASDAQ:AZRX) SEC Filings

DateFilerForm TypeView
06/01/2020
4:10 PM		AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2020
3:43 PM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2020
4:28 PM		AzurRx BioPharma (Filer)
Form 10-K/A
04/21/2020
7:15 AM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2020
8:51 PM		AzurRx BioPharma (Issuer)
Oakes Gregory (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2020
6:49 PM		AzurRx BioPharma (Issuer)
Oakes Gregory (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/14/2020
4:20 PM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2020
6:53 PM		AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2020
6:52 PM		AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2020
6:50 PM		AzurRx BioPharma (Issuer)
Riddell Alastair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2020
6:46 PM		AzurRx BioPharma (Issuer)
Spoor Johan M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2020
6:44 PM		AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2020
7:15 PM		AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2020
4:12 PM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
8:00 AM		AzurRx BioPharma (Subject)
LYTTON LAURENCE W (Filed by)
Form SC 13G/A
02/07/2020
4:15 PM		AzurRx BioPharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/29/2020
1:03 PM		AzurRx BioPharma (Subject)
Ross Edmund Burke Jr. (Filed by)
Form SC 13D/A
01/29/2020
1:01 PM		AzurRx BioPharma (Issuer)
Ross Edmund Burke Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
9:20 AM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2020
4:21 PM		AzurRx BioPharma (Filer)
Form 424B3
01/14/2020
11:15 PM		AzurRx BioPharma (Filer)
Form EFFECT
01/13/2020
4:09 PM		AzurRx BioPharma (Filer)
Form S-1/A
01/09/2020
3:10 PM		AzurRx BioPharma (Issuer)
Schneiderman Daniel H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2020
3:05 PM		AzurRx BioPharma (Issuer)
Schneiderman Daniel H (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/03/2020
8:45 PM		AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2019
4:13 PM		AzurRx BioPharma (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/30/2019
4:09 PM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2019
2:39 PM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2019
3:31 PM		AzurRx BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/14/2019
8:00 AM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2019
2:59 PM		AzurRx BioPharma (Filer)
Form DEF 14A
11/01/2019
3:30 PM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2019
3:35 PM		AzurRx BioPharma (Filer)
Form PRE 14A
10/22/2019
2:30 PM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2019
1:04 PM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2019
7:31 AM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2019
7:30 AM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2019
4:15 PM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2019
8:11 PM		AzurRx BioPharma (Issuer)
SAPIRSTEIN JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2019
8:08 PM		AzurRx BioPharma (Issuer)
SAPIRSTEIN JAMES (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/09/2019
5:03 AM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2019
1:29 PM		AzurRx BioPharma (Issuer)
Riddell Alastair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2019
1:27 PM		AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2019
1:25 PM		AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2019
1:24 PM		AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2019
4:25 PM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2019
4:28 PM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2019
4:21 PM		AzurRx BioPharma (Filer)
Form 424B5
07/17/2019
3:57 PM		AzurRx BioPharma (Filer)
Form 424B5
07/10/2019
1:36 PM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2019
5:46 PM		AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
5:42 PM		AzurRx BioPharma (Issuer)
Riddell Alastair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
5:41 PM		AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
5:37 PM		AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
11:15 PM		AzurRx BioPharma (Filer)
Form EFFECT
06/21/2019
7:10 PM		AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
Form 4/A
06/21/2019
7:08 PM		AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
Form 4/A
06/21/2019
7:04 PM		AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
Form 4/A
06/21/2019
7:01 PM		AzurRx BioPharma (Issuer)
Riddell Alastair (Reporting)
Form 4/A
06/21/2019
4:25 PM		AzurRx BioPharma (Filer)
Form S-3/A
06/21/2019
4:23 PM		AzurRx BioPharma (Filer)
Form 424B3
06/17/2019
8:51 PM		AzurRx BioPharma (Issuer)
Riddell Alastair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
8:50 PM		AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
8:49 PM		AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
8:48 PM		AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2019
11:19 PM		AzurRx BioPharma (Filer)
Form EFFECT
06/07/2019
4:00 PM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2019
8:36 AM		AzurRx BioPharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/04/2019
8:45 PM		AzurRx BioPharma (Filer)
Form S-3/A
05/23/2019
4:01 PM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2019
4:00 PM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2019
4:17 PM		AzurRx BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2019
3:05 PM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
8:28 AM		AzurRx BioPharma (Filer)
Form 424B5
05/07/2019
12:03 PM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
4:24 PM		AzurRx BioPharma (Filer)
Form 10-K/A
04/29/2019
7:27 PM		AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
7:24 PM		AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
7:22 PM		AzurRx BioPharma (Issuer)
Riddell Alastair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
7:20 PM		AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2019
2:15 PM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2019
8:50 AM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2019
7:56 AM		AzurRx BioPharma (Filer)
Form 424B5
04/01/2019
3:41 PM		AzurRx BioPharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2019
4:00 PM		AzurRx BioPharma (Subject)
Ross Edmund Burke Jr. (Filed by)
Form SC 13D/A
02/20/2019
7:29 AM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2019
8:45 PM		AzurRx BioPharma (Issuer)
Ross Edmund Burke Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
10:23 AM		AzurRx BioPharma (Subject)
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G/A
02/13/2019
3:42 PM		AzurRx BioPharma (Subject)
LYTTON LAURENCE W (Filed by)
Form SC 13G/A
01/29/2019
2:44 PM		AzurRx BioPharma (Subject)
BALK MATTHEW (Filed by)
Form SC 13G/A
01/07/2019
5:49 PM		AzurRx BioPharma (Issuer)
Ross Edmund Burke Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
5:47 PM		AzurRx BioPharma (Issuer)
Spoor Johan M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
5:44 PM		AzurRx BioPharma (Issuer)
Shenouda Maged (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
5:03 PM		AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
5:01 PM		AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
4:58 PM		AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
4:55 PM		AzurRx BioPharma (Issuer)
Riddell Alastair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2018
4:07 PM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2018
3:39 PM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2018
8:37 PM		AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.